| Not Yet Recruiting | Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease NCT07280702 | University of Texas Southwestern Medical Center | Phase 4 |
| Recruiting | Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic D NCT07087912 | University of Sao Paulo General Hospital | Phase 4 |
| Recruiting | Preventing Structural Damage in Early Psoriatic Arthritis NCT07486843 | Chinese University of Hong Kong | Phase 4 |
| Not Yet Recruiting | Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis NCT07460739 | Assistance Publique - Hôpitaux de Paris | N/A |
| Not Yet Recruiting | Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis NCT07443956 | NHS Greater Glasgow and Clyde | N/A |
| Not Yet Recruiting | Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578 | Seismic Therapeutic AU Pty Ltd | Phase 1 |
| Not Yet Recruiting | Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Rand NCT07111494 | Medical College of Wisconsin | Phase 4 |
| Recruiting | Oxidative Stress in Autoimmune Rheumatic Diseases NCT07536529 | University of Thessaly | — |
| Recruiting | Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis NCT07298265 | Charite University, Berlin, Germany | — |
| Not Yet Recruiting | Mass Spectrometry-based Immune Profiling in Autoimmune Diseases NCT07188285 | Peking University People's Hospital | — |
| Recruiting | REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases NCT07160231 | Sint Maartenskliniek | Phase 4 |
| Recruiting | Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselku NCT07166315 | Adelphi Real World | — |
| Not Yet Recruiting | Personalized Outreach for Equitable Treatment in Rheumatology NCT07022756 | University of British Columbia | N/A |
| Not Yet Recruiting | Right Ventricular Strain in Detecting Subclinical Right Ventricular Systolic Dysfunction in Psoriatic Arthriti NCT07046312 | Ain Shams University | — |
| Recruiting | A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Tri NCT06990152 | Dr. Schär AG / SPA | N/A |
| Not Yet Recruiting | Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments NCT06918886 | Bezmialem Vakif University | — |
| Recruiting | Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy NCT07150000 | University of Bonn | — |
| Not Yet Recruiting | A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic NCT06766552 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Recruiting | Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis NCT06628206 | LAPIX Therapeutics Inc. | Phase 1 |
| Recruiting | AYLo - AutoimmunitY and Loss of y NCT06696027 | University of Bonn | — |
| Recruiting | COMFI - a COMbined Fatigue Intervention NCT06666452 | The Danish Center for Expertise in Rheumatology | N/A |
| Recruiting | Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis. NCT06630715 | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | — |
| Recruiting | Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620 | Brain Inflammation Collaborative | — |
| Recruiting | Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity NCT07277491 | Cairo University | — |
| Completed | Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment NCT06666114 | Novartis Pharmaceuticals | — |
| Completed | A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korea NCT04541810 | AbbVie | — |
| Completed | A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database NCT05421442 | Bristol-Myers Squibb | — |
| Active Not Recruiting | A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who NCT03671148 | AbbVie | Phase 3 |
| Completed | Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants NCT03419143 | Bristol-Myers Squibb | — |
| Terminated | UCB Cimzia Pregnancy Follow-up Study NCT02775656 | UCB BIOSCIENCES, Inc. | — |
| Withdrawn | Psoriatic Arthritis Treat to Target vs. Usual Care NCT01692912 | Pope Research Corporation | N/A |
| Completed | Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors NCT07041112 | Juan Ruano Ruiz | — |
| Completed | EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondyl NCT01078402 | AbbVie (prior sponsor, Abbott) | — |